TY - JOUR T1 - EFFECTS OF COVID-19 INFECTION DURING PREGNANCY AND NEONATAL PROGNOSIS: WHAT IS THE EVIDENCE? JF - medRxiv DO - 10.1101/2020.04.17.20069435 SP - 2020.04.17.20069435 AU - Álvaro Francisco Lopes Sousa AU - Herica Emilia Félix de Carvalho AU - Layze Braz de Oliveira AU - Guilherme Schneider AU - Emerson Lucas Silva Camargo AU - Evandro Watanabe AU - Denise de Andrade AU - Ana Fátima Carvalho AU - Isabel Amélia Costa Mendes AU - Inês Fronteira Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/22/2020.04.17.20069435.abstract N2 - Background Little is known about how COVID-19 infection affects pregnant women, as well as about the possibility of vertical transmission or that of premature labor. Thus, this study’s objective was to identify existing evidence to directive public policies.Method Systematic literature review assessing papers published in the most comprehensive databases in the field of health.Results 12 papers were eligible. A total of 119 pregnant women aged between 22 and 42 years old and between the 12th and 41st weeks were analyzed; 90 children were born. Most pregnant women acquired the infection in the third trimester of pregnancy, 97.4% were diagnosed before hospitalization based on signs and symptoms. There was no maternal death and no vertical transmission was confirmed.Conclusions pregnant women must be cautious and vigilant because their exposure to the virus, even if at the end of a pregnancy, has important repercussions, especially for the type of labor.Competing Interest StatementThe authors have declared no competing interest.Funding StatementCoordenacão de Aperfeiçoamento de Pessoal do Nivel SuperiorAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAvailable upon request to the authors ER -